Alex J. Walker
Risk of venous thromboembolism in people with lung cancer: a cohort study using linked UK healthcare data
Walker, Alex J.; Baldwin, David R.; Card, Timothy R.; Powell, Helen A.; Hubbard, Richard B.; Grainge, Matthew J.
David R. Baldwin
Dr TIM CARD firstname.lastname@example.org
Clinical Associate Professor
Helen A. Powell
RICHARD HUBBARD email@example.com
Blf/Gsk Professor of Epidemiological Resp Research
MATTHEW GRAINGE MATTHEW.GRAINGE@NOTTINGHAM.AC.UK
Background: Venous thromboembolism is a potentially preventable cause of death in people with lung cancer. Identification of those most at risk and high risk periods may provide the opportunity for better targeted intervention.
Methods: We conducted a cohort study using the Clinical Practice Research Datalink linked to Hospital Episode Statistics and Cancer Registry data. Our cohort comprised 10,598 people with lung cancer diagnosed between 1997 and 2006 with follow-up continuing to the end of 2010. Cox regression analysis was performed to determine which demographic, tumour and treatment-related factors (time-varying effects of chemotherapy and surgery) independently affected VTE risk. We also determined the effect of a VTE diagnosis on the survival of people with lung cancer.
Results: People with lung cancer had an overall VTE incidence of 39.2 per 1000 person years (95% confidence Interval (CI), 35.4-43.5), though rates varied depending on the patient group and treatment course. Independent factors associated with increased VTE risk were: metastatic disease (hazard ratio (HR)=1.9, CI 1.2, 3.0 vs. local disease); adenocarcinoma sub-type (HR =2.0, CI 1.5, 2.7, vs. squamous cell; chemotherapy administration, (HR=2.1, CI 1.4, 3.0 vs. outside chemotherapy courses); and diagnosis via emergency hospital admission (HR=1.7, CI 1.2-2.3 vs. other routes to diagnosis). Patients with VTE had an approximately 50% higher risk of mortality than those without VTE.
Conclusions: People with lung cancer have especially high risk of VTE if they have advanced disease, adenocarcinoma, or are undergoing chemotherapy. Presence of VTE is an independent risk factor for death.
Walker, A. J., Baldwin, D. R., Card, T. R., Powell, H. A., Hubbard, R. B., & Grainge, M. J. (in press). Risk of venous thromboembolism in people with lung cancer: a cohort study using linked UK healthcare data. British Journal of Cancer, 115(1), https://doi.org/10.1038/bjc.2016.143
|Journal Article Type||Article|
|Acceptance Date||Apr 26, 2016|
|Online Publication Date||Jun 2, 2016|
|Deposit Date||Jun 29, 2016|
|Publicly Available Date||Jun 29, 2016|
|Journal||British Journal of Cancer|
|Publisher||Cancer Research UK|
|Peer Reviewed||Peer Reviewed|
deep vein thrombosis
Walker Br J Cancer.pdf
Copyright information regarding this work can be found at the following address: http://eprints.nottingham.ac.uk/end_user_agreement.pdf
You might also like
The global incidence of bullous pemphigoid: a systematic review and meta-analysis